Lv51
1200 积分 2020-11-13 加入
Final Analysis of the Neotorch Study: Perioperative Toripalimab in Combination with Chemotherapy for Patients with Stage Ⅱ/Ⅲ Resectable Non-Small Cell Lung Cancer
8小时前
已关闭
Final Analysis of the Neotorch Study: Perioperative Toripalimab in Combination with Chemotherapy for Patients with Stage Ⅱ/Ⅲ Resectable Non-Small Cell Lung Cancer
9小时前
已关闭
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma
1个月前
已完结
A Phase 1 study of subcutaneous toripalimab in recurrent or metastatic nasopharyngeal carcinoma
1个月前
已完结
A Phase 1 study of subcutaneous toripalimab in recurrent or metastatic nasopharyngeal carcinoma
1个月前
已完结
Comparative Cost-Effectiveness of First-Line Immunotherapy-Based Regimens for Advanced Triple-Negative Breast Cancer
1个月前
已完结
Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
1个月前
已完结
Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysis
2个月前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
7个月前
已完结
The impact of low HER2 expression on clinicopathological features and clinical outcomes in patients with metastatic gastric cancer
7个月前
已完结
皖公网安备34019202002308
